Rebecca E. Kaufman

587 total citations
8 papers, 416 citations indexed

About

Rebecca E. Kaufman is a scholar working on Clinical Psychology, Experimental and Cognitive Psychology and Pharmacology. According to data from OpenAlex, Rebecca E. Kaufman has authored 8 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Clinical Psychology, 4 papers in Experimental and Cognitive Psychology and 2 papers in Pharmacology. Recurrent topics in Rebecca E. Kaufman's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers), Treatment of Major Depression (2 papers) and Advanced MRI Techniques and Applications (2 papers). Rebecca E. Kaufman is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers), Treatment of Major Depression (2 papers) and Advanced MRI Techniques and Applications (2 papers). Rebecca E. Kaufman collaborates with scholars based in United States. Rebecca E. Kaufman's co-authors include Naomi M. Simon, Mark H. Pollack, Elizabeth A. Hoge, Paul J. Zak, J. Eric Jensen, Perry F. Renshaw, John J. Worthington, Candice Chow, Karleyton C. Evans and Alan J. Fischman and has published in prestigious journals such as JAMA, Neuropsychopharmacology and Progress in Neuro-Psychopharmacology and Biological Psychiatry.

In The Last Decade

Rebecca E. Kaufman

8 papers receiving 403 citations

Peers

Countries citing papers authored by Rebecca E. Kaufman

Since Specialization

Citations

This map shows the geographic impact of Rebecca E. Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca E. Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca E. Kaufman more than expected).

Fields of papers citing papers by Rebecca E. Kaufman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca E. Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca E. Kaufman. The network helps show where Rebecca E. Kaufman may publish in the future.

Co-authorship network of co-authors of Rebecca E. Kaufman

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca E. Kaufman. A scholar is included among the top collaborators of Rebecca E. Kaufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca E. Kaufman. Rebecca E. Kaufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Open‐Label Support for Duloxetine for the Treatment of Panic Disorder 2009 ·CNS Neuroscience & Therapeutics ·Naomi M. Simon, Rebecca E. Kaufman, Elizabeth A. Hoge, John J. Worthington, (unknown), (unknown), Mark H. Pollack	25
2	Brain GABA levels in patients with bipolar disorder 2009 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Rebecca E. Kaufman, Michael J. Ostacher, Elizabeth H. Marks, Naomi M. Simon, Roy H. Perlis, J. Eric Jensen, Perry F. Renshaw, Mark H. Pollack	35
3	A Comparison of Emotional Approach Coping (EAC) between Individuals with Anxiety Disorders and Nonanxious Controls 2009 ·CNS Neuroscience & Therapeutics ·Luana Marques, Rebecca E. Kaufman, Richard T. LeBeau, Samantha J. Moshier, Michael W. Otto, Mark H. Pollack, Naomi M. Simon	7
4	Oxytocin Levels in Social Anxiety Disorder 2008 ·CNS Neuroscience & Therapeutics ·Elizabeth A. Hoge, Mark H. Pollack, Rebecca E. Kaufman, Paul J. Zak, Naomi M. Simon	168
5	A PET Study of Tiagabine Treatment Implicates Ventral Medial Prefrontal Cortex in Generalized Social Anxiety Disorder 2008 ·Neuropsychopharmacology ·Karleyton C. Evans, Naomi M. Simon, Darin D. Dougherty, Elizabeth A. Hoge, John J. Worthington, Candice Chow, Rebecca E. Kaufman, Andrea L. Gold, Alan J. Fischman, Mark H. Pollack, Scott L. Rauch	55
6	Aripiprazole as Augmentation Treatment of Refractory Generalized Anxiety Disorder and Panic Disorder 2008 ·CNS Spectrums ·Elizabeth A. Hoge, John J. Worthington, Rebecca E. Kaufman, (unknown), Mark H. Pollack, Naomi M. Simon	38
7	High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: Response to treatment with levetiracetam 2007 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Mark H. Pollack, J. Eric Jensen, Naomi M. Simon, Rebecca E. Kaufman, Perry F. Renshaw	86
8	Overdose treatment. Addict folklore and medical reality 1974 ·JAMA ·Rebecca E. Kaufman	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact